View More View Less
  • 1 Tabriz University of Medical Sciences, Tabriz, Iran
  • 2 Tabriz University of Medical Sciences, Tabriz, Iran
  • 3 Tabriz University of Medical Sciences, Tabriz, Iran
  • 4 Tabriz University of Medical Sciences, Tabriz, Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Interleukin-13 (IL-13) as a pleiotropic cytokine acts through the IL-13Ra1/IL-4Ra complex to induce activation responses which contribute to the inflammatory diseases. Genetic polymorphisms in IL-13 and its receptor components have been proved to be associated with higher disease prevalence rates. Animal models such as in IL-13 deficient mice and transgenic animals also have been confirmed the critical role of this cytokine in the immune responses, mostly by IL-13 neutralization and IL-13/IL-4 dual neutralization strategies. This review highlights IL-13 structure as well as its pivotal roles in the normal physiologic and pathologic states. It is followed by a section on the recent findings on IL-13 receptors and signalling mechanisms to briefly summarize its functions in the immune systems. IL-13 roles in the human diseases such as asthma, systematic sclerosis, and some inflammatory diseases are described concisely. Finally some of the ongoing therapeutic applications are presented to comprehensively review IL-13 mediator roles.

  • 1.

    Rengarajan, J., Szabo, S. J., Glimcher, L. H.: Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21, 479483 (2000).

  • 2.

    Brown, K. D., Zurawski, S. M., Mosmann, T. R., Zurawski, G.: A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol 142, 679687 (1989).

    • Search Google Scholar
    • Export Citation
  • 3.

    Cherwinski, H. M., Schumacher, J. H., Brown, K. D., Mosmann, T.: Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 166, 12291244 (1987).

    • Search Google Scholar
    • Export Citation
  • 4.

    Mosmann, T. R., Cherwinski, H., Bond, M., Giedlin, M., Coffman, R.: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 23482357 (1986).

    • Search Google Scholar
    • Export Citation
  • 5.

    Minty, A., Chalon, P., Derocq, J. M., Dumont, X., Guillemot, J. C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., et al.: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362, 248250 (1993).

    • Search Google Scholar
    • Export Citation
  • 6.

    Morgan, J. G., Dolganov, G. M., Robbins, S. E., Hinton, L. M., Lovett, M.: The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res 20, 51735179 (1992).

    • Search Google Scholar
    • Export Citation
  • 7.

    McKenzie, A. N., Culpepper, J. A., de Waal Malefyt, R., Briere, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B. G., Menon, S., et al.: Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A 90, 37353739 (1993).

    • Search Google Scholar
    • Export Citation
  • 8.

    de Vries, J. E.: Molecular and biological characteristics of interleukin-13. Chem Immunol 63, 204218 (1996).

  • 9.

    Leonard, W. J., Lin, J. X.: Cytokine receptor signaling pathways. J Allergy Clin Immunol 105, 877888 (2000).

  • 10.

    Eisenmesser, E. Z., Horita, D. A., Altieri, A. S., Byrd, R. A.: Solution structure of interleukin-13 and insights into receptor engagement. J Mol Biol 310, 231241 (2001).

    • Search Google Scholar
    • Export Citation
  • 11.

    Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., Haussler, D.: The human genome browser at UCSC. Genome Research 12, 9961006 (2002).

    • Search Google Scholar
    • Export Citation
  • 12.

    Smirnov, D. V., Smirnova, M. G., Korobko, V. G., Frolova, E. I.: Tandem arrangement of human genes for interleukin-4 and interleukin-13: Resemblance in their organization. Gene 155, 277281 (1995).

    • Search Google Scholar
    • Export Citation
  • 13.

    Marsh, D. G., Neely, J. D., Breazeale, D. R., Ghosh, B., Freidhoff, L. R., Ehrlich-Kautzky, E., Schou, C., Krishnaswamy, G., Beaty, T. H.: Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264, 11521156 (1994).

    • Search Google Scholar
    • Export Citation
  • 14.

    Meyers, D. A., Postma, D. S., Panhuysen, C. I., Xu, J., Amelung, P. J., Levitt, R. C., Bleecker, E. R.: Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23, 464470 (1994).

    • Search Google Scholar
    • Export Citation
  • 15.

    Postma, D. S., Bleecker, E. R., Amelung, P. J., Holroyd, K. J., Xu, J., Panhuysen, C. I., Meyers, D. A., Levitt, R. C.: Genetic susceptibility to asthma--Bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 333, 894900 (1995).

    • Search Google Scholar
    • Export Citation
  • 16.

    Daniels, S. E., Bhattacharrya, S., James, A., Leaves, N. I., Young, A., Hill, M. R., Faux, J. A., Ryan, G. F., le Souef, P. N., Lathrop, G. M., Musk, A. W., Cookson, W. O.: A genomewide search for quantitative trait loci underlying asthma. Nature 383, 247250 (1996).

    • Search Google Scholar
    • Export Citation
  • 17.

    Park, L. S., Friend, D., Sassenfeld, H. M., Urdal, D. L.: Characterization of the human B cell stimulatory factor 1 receptor. J Exp Med 166, 476488 (1987).

    • Search Google Scholar
    • Export Citation
  • 18.

    Chomarat, P., Banchereau, J.: Interleukin-4 and interleukin-13: Their similarities and discrepancies. Int Rev Immunol 17, 152 (1998).

    • Search Google Scholar
    • Export Citation
  • 19.

    Tsarbopoulos, A., Varnerin, J., Cannon-Carlson, S., Wylie, D., Pramanik, B., Tang, J., Nagabhushan, T. L.: Mass spectrometric mapping of disulfide bonds in recombinant human interleukin-13. J Mass Spectrom 35, 446453 (2000).

    • Search Google Scholar
    • Export Citation
  • 20.

    Vock, C., Yildirim, A. Ö., Wagner, C., Schlick, S., Lunding, L. P., Lee, C. G., Elias, J. A., Fehrenbach, H., Wegmann, M.: Distal airways are protected from goblet cell metaplasia by diminished expression of IL-13 signaling components. Clin Exp Allergy 45, 14471458 (2015).

    • Search Google Scholar
    • Export Citation
  • 21.

    Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., Donaldson, D. D.: Interleukin-13: Central mediator of allergic asthma. Science 282, 22582261 (1998).

    • Search Google Scholar
    • Export Citation
  • 22.

    Grunig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., Corry, D. B.: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 22612263 (1998).

    • Search Google Scholar
    • Export Citation
  • 23.

    Yi, T., Mui, A. L., Krystal, G., Ihle, J. N.: Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13, 75777586 (1993).

    • Search Google Scholar
    • Export Citation
  • 24.

    Chen, H. E., Chang, S., Trub, T., Neel, B. G.: Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 16, 36853697 (1996).

    • Search Google Scholar
    • Export Citation
  • 25.

    Klingmuller, U., Lorenz, U., Cantley, L. C., Neel, B. G., Lodish, H. F.: Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729738 (1995).

    • Search Google Scholar
    • Export Citation
  • 26.

    Paulson, R. F., Vesely, S., Siminovitch, K. A., Bernstein, A.: Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13, 309315 (1996).

    • Search Google Scholar
    • Export Citation
  • 27.

    Gelderloos, J. A., Anderson, S. M.: Over-expression of protein tyrosine phosphatase 1 (PTP1) alters IL-3-dependent growth and tyrosine phosphorylation. Oncogene 13, 23672378 (1996).

    • Search Google Scholar
    • Export Citation
  • 28.

    Imani, F., Rager, K. J., Catipovic, B., Marsh, D. G.: Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem 272, 79277931 (1997).

    • Search Google Scholar
    • Export Citation
  • 29.

    Nagarkar, D., Ramirez-Carrozzi, V., Choy, D., Lee, K., Soriano, R., Abbas, A., Modrusan, Z., Pappu, R., Arron, J.: Human mast cells and type 2 innate lymphoid cells activate gene expression and mucus composition in human bronchial epithelial cells via IL-13. Eur Respir J 44, P3898 (2014).

    • Search Google Scholar
    • Export Citation
  • 30.

    Wadsworth, S., Singhera, G., Dorscheid, D., Yang, S.: The regulation of interleukin-13 receptors in airway epithelial repair. Am J Respir Crit Care Med 189, A1066 (2014).

    • Search Google Scholar
    • Export Citation
  • 31.

    Mitchel, J., Antoniak, S., Kim, S.-H., McGill, M., Randell, S., Shore, S., Mackman, N., Park, J.-A.: IL-13 augments compression-induced exosomal tissue factor release from bronchial epithelial cells. The FASEB Journal 29, 863.21 (2015).

    • Search Google Scholar
    • Export Citation
  • 32.

    Haque, S. J., Harbor, P., Tabrizi, M., Yi, T., Williams, B. R.: Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4-and IL-13-dependent signal transduction. J Biol Chem 273, 3389333896 (1998).

    • Search Google Scholar
    • Export Citation
  • 33.

    Hershey, G. K., Friedrich, M. F., Esswein, L. A., Thomas, M. L., Chatila, T. A.: The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337, 17201725 (1997).

    • Search Google Scholar
    • Export Citation
  • 34.

    Haque, S. J., Wu, Q., Kammer, W., Friedrich, K., Smith, J. M., Kerr, I. M., Stark, G. R., Williams, B. R.: Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. Proc Natl Acad Sci U S A 94, 85638568 (1997).

    • Search Google Scholar
    • Export Citation
  • 35.

    Reichel, M., Nelson, B. H., Greenberg, P. D., Rothman, P. B.: The IL-4 receptor alphachain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression. J Immunol 158, 58605867 (1997).

    • Search Google Scholar
    • Export Citation
  • 36.

    Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., Miyajima, A.: A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 14, 28162826 (1995).

    • Search Google Scholar
    • Export Citation
  • 37.

    Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., Hilton, D. J.: A family of cytokineinducible inhibitors of signalling. Nature 387, 917921 (1997).

    • Search Google Scholar
    • Export Citation
  • 38.

    Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S., Yoshimura, A.: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921924 (1997).

    • Search Google Scholar
    • Export Citation
  • 39.

    Galizzi, J. P., Zuber, C. E., Harada, N., Gorman, D. M., Djossou, O., Kastelein, R., Banchereau, J., Howard, M., Miyajima, A.: Molecular cloning of a cDNA encoding the human interleukin 4 receptor. Int Immunol 2, 669675 (1990).

    • Search Google Scholar
    • Export Citation
  • 40.

    Idzerda, R. L., March, C. J., Mosley, B., Lyman, S. D., Vanden Bos, T., Gimpel, S. D., Din, W. S., Grabstein, K. H., Widmer, M. B., Park, L. S., et al.: Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 171, 861873 (1990).

    • Search Google Scholar
    • Export Citation
  • 41.

    Aversa, G., Punnonen, J., Cocks, B. G., de Waal Malefyt, R., Vega, F., Jr., Zurawski, S. M., Zurawski, G., de Vries, J. E.: An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: Support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178, 22132218 (1993).

    • Search Google Scholar
    • Export Citation
  • 42.

    Kruse, N., Tony, H. P., Sebald, W.: Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J 11, 32373244 (1992).

    • Search Google Scholar
    • Export Citation
  • 43.

    Lefort, S., Vita, N., Reeb, R., Caput, D., Ferrara, P.: IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells. FEBS Lett 366, 122126 (1995).

    • Search Google Scholar
    • Export Citation
  • 44.

    Zurawski, S. M., Chomarat, P., Djossou, O., Bidaud, C., McKenzie, A. N., Miossec, P., Banchereau, J., Zurawski, G.: The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270, 1386913878 (1995).

    • Search Google Scholar
    • Export Citation
  • 45.

    Noguchi, M., Yi, H., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W., Leonard, W. J.: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147157 (1993).

    • Search Google Scholar
    • Export Citation
  • 46.

    Matthews, D. J., Clark, P. A., Herbert, J., Morgan, G., Armitage, R. J., Kinnon, C., Minty, A., Grabstein, K. H., Caput, D., Ferrara, P., et al.: Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodefi-cient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85, 3842 (1995).

    • Search Google Scholar
    • Export Citation
  • 47.

    Obiri, N. I., Murata, T., Debinski, W., Puri, R. K.: Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor. J Biol Chem 272, 2025120258 (1997).

    • Search Google Scholar
    • Export Citation
  • 48.

    Aman, M. J., Tayebi, N., Obiri, N. I., Puri, R. K., Modi, W. S., Leonard, W. J.: cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271, 2926529270 (1996).

    • Search Google Scholar
    • Export Citation
  • 49.

    Caput, D., Laurent, P., Kaghad, M., Lelias, J. M., Lefort, S., Vita, N., Ferrara, P.: Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271, 1692116926 (1996).

    • Search Google Scholar
    • Export Citation
  • 50.

    Hilton, D. J., Zhang, J. G., Metcalf, D., Alexander, W. S., Nicola, N. A., Willson, T. A.: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 93, 497501 (1996).

    • Search Google Scholar
    • Export Citation
  • 51.

    Miloux, B., Laurent, P., Bonnin, O., Lupker, J., Caput, D., Vita, N., Ferrara, P.: Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett 401, 163166 (1997).

    • Search Google Scholar
    • Export Citation
  • 52.

    He, Y. W., Malek, T. R.: The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J Immunol 155, 912 (1995).

    • Search Google Scholar
    • Export Citation
  • 53.

    Andrews, R., Rosa, L., Daines, M., Khurana Hershey, G.: Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: Demonstration of species specificity. J Immunol 166, 17161722 (2001).

    • Search Google Scholar
    • Export Citation
  • 54.

    Gemou-Engesaeth, V.: Serum interleukin 13 (IL-13) and surfactant protein D (SP-D) expression is differentially associated with disease status in pediatric asthma patients. J Allergy Clin Immunol 133, AB148 (2014).

    • Search Google Scholar
    • Export Citation
  • 55.

    Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O’Hara, R. M., Jr., Beier, D. R., Turner, K. J., Wood, C. R., Collins, M.: The murine IL-13 receptor alpha 2: Molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 161, 23172324 (1998).

    • Search Google Scholar
    • Export Citation
  • 56.

    Guo, J., Apiou, F., Mellerin, M. P., Lebeau, B., Jacques, Y., Minvielle, S.: Chromosome mapping and expression of the human interleukin-13 receptor. Genomics 42, 141145 (1997).

    • Search Google Scholar
    • Export Citation
  • 57.

    Daines, M. O., Hershey, G. K.: A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J Biol Chem 277, 1038710393 (2002).

    • Search Google Scholar
    • Export Citation
  • 58.

    Mandal, D., Levine, A. D.: Elevated IL-13Ra2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway. Inflamm Bowel Dis 16, 753764 (2010).

    • Search Google Scholar
    • Export Citation
  • 59.

    Chen, W., Sivaprasad, U., Gibson, A. M., Ericksen, M. B., Cunningham, C. M., Bass, S. A., Kinker, K. G., Finkelman, F. D., Wills-Karp, M., Khurana Hershey, G. K.: IL-13 receptor a2 contributes to development of experimental allergic asthma. J Allergy Clin Immunol 132, 951958. e956 (2013).

    • Search Google Scholar
    • Export Citation
  • 60.

    Konstantinidis, A., Puddicombe, S., Mochizuki, A., Sheth, P., Yang, I. A., Yoshisue, H., Wilson, S., Davies, D., Holgate, S., Holloway, J.: Cellular localization of interleukin 13 receptor alpha 2 in human primary bronchial epithelial cells and fibroblasts. J Investig Allergol Clin Immunol 18, 174 (2008).

    • Search Google Scholar
    • Export Citation
  • 61.

    Hersh ey, G. K.: IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111, 677690; quiz 691 (2003).

  • 62.

    Hucka bee, M., Newcomb, D., Boswell, M., Goleniewska, K., Reiss, S., Peebles, R.: TGF-ß, IL-1ß, and IL-23 are required for IL-13Ra1 expression on human Th17 cells and IL-13 attenuates IL-17A production at restimulation. J Allergy Clin Immunol 127, AB68 (2011).

    • Search Google Scholar
    • Export Citation
  • 63.

    Dhakal, M., Hardaway, J. C., Guloglu, F. B., Miller, M. M., Hoeman, C. M., Zaghouani, A. A., Wan, X., Rowland, L. M., Cascio, J. A., Sherman, M. P.: IL-13Ra1 is a surface marker for M2 macrophages influencing their differentiation and function. Eur J Immunol 44, 842855 (2014).

    • Search Google Scholar
    • Export Citation
  • 64.

    Takeda, K., Kamanaka, M., Tanaka, T., Kishimoto, T., Akira, S.: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157, 32203222 (1996).

    • Search Google Scholar
    • Export Citation
  • 65.

    Kaplan, M. H., Schindler, U., Smiley, S. T., Grusby, M. J.: Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313319 (1996).

    • Search Google Scholar
    • Export Citation
  • 66.

    Welham, M. J., Learmonth, L., Bone, H., Schrader, J. W.: Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem 270, 1228612296 (1995).

    • Search Google Scholar
    • Export Citation
  • 67.

    Wills-Karp, M.: IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 107, 918 (2001).

  • 68.

    Keegan, A. D., Nelms, K., White, M., Wang, L. M., Pierce, J. H., Paul, W. E.: An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76, 811820 (1994).

    • Search Google Scholar
    • Export Citation
  • 69.

    Kashiwada, M., Giallourakis, C. C., Pan, P. Y., Rothman, P. B.: Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J Immunol 167, 63826387 (2001).

    • Search Google Scholar
    • Export Citation
  • 70.

    Ryan, J. J. , McReynolds, L. J., Keegan, A., Wang, L. H., Garfein, E., Rothman, P., Nelms, K., Paul, W. E.: Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4, 123132 (1996).

    • Search Google Scholar
    • Export Citation
  • 71.

    Callard, R. E., Matthews, D. J., Hibbert, L. M.: Interleukin 4 and interleukin 13: same response, different receptors. Biochem Soc Trans 25, 451455 (1997).

    • Search Google Scholar
    • Export Citation
  • 72.

    Boulay, J.-L., Paul, W. E.: The interleukin-4 family of lymphokines. Curr Opin Immunol 4, 294298 (1992).

  • 73.

    McKenzie, A., Li, X., Largaespada, D., Sato, A., Kaneda, A., Zurawski, S., Doyle, E., Milatovich, A., Francke, U., Copeland, N.: Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 150, 54365444 (1993).

    • Search Google Scholar
    • Export Citation
  • 74.

    Heinzmann, A., Mao, X.-Q., Akaiwa, M., Kreomer, R., Gao, P.-S., Ohshima, K., Umeshita, R., Abe, Y., Braun, S., Yamashita, T.: Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 9, 549559 (2000).

    • Search Google Scholar
    • Export Citation
  • 75.

    Chen, W., S ivaprasad, U., Tabata, Y., Gibson, A. M., Stier, M. T., Finkelman, F. D., Hershey, G. K. K.: IL-13Ra2 membrane and soluble isoforms differ in humans and mice. J Immunol 183, 78707876 (2009).

    • Search Google Scholar
    • Export Citation
  • 76.

    Akinbami, O. J., Moorman, J. E., Liu, X.: Asthma prevalence, health care use, and mortality: United States, 2005–2009. Natl Health Stat Report 32, 114 (2011).

    • Search Google Scholar
    • Export Citation
  • 77.

    Wills-Karp, M.: Interleukin-13 in asthma pathogenesis. Immunol Rev 202, 175190 (2004).

  • 78.

    Murphy, D. M.: Recent advances in the pathophysiology of asthma. CHEST Journal 137, 14171426 (2010).

  • 79.

    Wills-Karp, M.: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17, 255281 (1999).

  • 80.

    Vercelli, D., Gozdz, J., von Mutius, E.: Innate lymphoid cells in asthma: When innate immunity comes in a Th2 flavor. Curr Opin Allergy Clin Immunol 14, 2934 (2014).

    • Search Google Scholar
    • Export Citation
  • 81.

    Sterk, P. J., Lutter, R.: Asthma phenotyping: TH2-high, TH2-low, and beyond. J Allergy Clin Immunol 133, 395396 (2014).

  • 82.

    Lukacs, N. W., Tekkanat, K. K.: Role of chemokines in asthmatic airway inflammation. Immunol Rev 177, 2130 (2000).

  • 83.

    Brusselle, G., Kips, J., Joos, G., Bluethmann, H., Pauwels, R.: Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 12, 254259 (1995).

    • Search Google Scholar
    • Export Citation
  • 84.

    Kuperman, D., Schofield, B., Wills-Karp, M., Grusby, M. J.: Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187, 939948 (1998).

    • Search Google Scholar
    • Export Citation
  • 85.

    Gavett, S. H., O’Hearn, D. J., Karp, C. L., Patel, E. A., Schofield, B. H., Finkelman, F. D., Wills-Karp, M.: Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol 272, L253261 (1997).

    • Search Google Scholar
    • Export Citation
  • 86.

    Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., Elias, J. A.: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103, 779788 (1999).

    • Search Google Scholar
    • Export Citation
  • 87.

    Webb, D. C., McKenzie, A. N., Koskinen, A. M., Yang, M., Mattes, J., Foster, P. S.: Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 165, 108113 (2000).

    • Search Google Scholar
    • Export Citation
  • 88.

    Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N., Donaldson, D. D., DeKruyff, R. H., Umetsu, D. T.: Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167, 46684675 (2001).

    • Search Google Scholar
    • Export Citation
  • 89.

    Ingram, J. L., Kraft, M.: IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies. J Allergy Clin Immunol 130, 829842 (2012).

    • Search Google Scholar
    • Export Citation
  • 90.

    Elias, J. A., Lee, C. G.: IL-13 in asthma: the successful integration of lessons from mice and humans. Am J Respir Crit Care Med 183, 957958 (2011).

    • Search Google Scholar
    • Export Citation
  • 91.

    Bottema, R. W., Nolte, I. M., Howard, T. D., Koppelman, G. H., Dubois, A. E., de Meer, G., Kerkhof, M., Bleecker, E. R., Meyers, D. A., Postma, D. S.: Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol 153, 259267 (2010).

    • Search Google Scholar
    • Export Citation
  • 92.

    Hussain, S., Tahir, A.: IL-13 gene polymorphisms and their association with atopic asthma and rhinitis in Pakistani patients. Iran J Allergy Asthma Immunol 13, 298299 (2014).

    • Search Google Scholar
    • Export Citation
  • 93.

    Undarmaa, S., Mashimo, Y., Hattori, S., Shimojo, N., Fujita, K., Miyatake, A., Doi, S., Kohno, Y., Okamoto, Y., Hirota, T.: Replication of genetic association studies in asthma and related phenotypes. J Human Genet 55, 342349 (2010).

    • Search Google Scholar
    • Export Citation
  • 94.

    Shazia, M., Kanza, M., Mehwish, I., Irum, S., Farida, A., Asifa, A.: IL-13 gene polymorphisms and their association with atopic asthma and rhinitis in Pakistani patients. Iran J Allergy Asthma Immunol 12, (2013).

    • Search Google Scholar
    • Export Citation
  • 95.

    Nie, W., Liu, Y., Bian, J., Li, B., Xiu, Q.: Effects of polymorphisms-1112C/T and+ 2044A/G in interleukin-13 gene on asthma risk: A meta-analysis. PLoS ONE 8, e56065 (2013).

    • Search Google Scholar
    • Export Citation
  • 96.

    Vercelli, D.: Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 8, 169182 (2008).

  • 97.

    Brightling, C., Saha, S., Hollins, F.: Interleukin-13: prospects for new treatments. Clin Exp Allergy 40, 4249 (2010).

  • 98.

    Hershey, G. K. K.: IL-13 receptors and signaling pathways: An evolving web. J Allergy Clin Immunol 111, 677690 (2003).

  • 99.

    Mathew, A., MacLean, J. A., DeHaan, E., Tager, A. M., Green, F. H., Luster, A. D.: Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 193, 10871096 (2001).

    • Search Google Scholar
    • Export Citation
  • 100.

    Francisco, D., Thomas, J., Lugogo, N., Que, L., Ledford, J., Choudhury, S., Beaver, D., Kraft, M., Wang, Y.: Surfactant protein A inhibits Il-13-induced pro-inflammatory response in asthmatic airway epithelial cells. Am J Respir Crit Care Med 187, A3555 (2013).

    • Search Google Scholar
    • Export Citation
  • 101.

    Gabrielli, A., Avvedimento, E. V., Krieg, T.: Scleroderma. N Engl J Med 360, 19892003 (2009).

  • 102.

    Gu, Y. S., Kong, J., Cheema, G. S., Keen, C. L., Wick, G., Gershwin, M. E.: The immunobiology of systemic sclerosis. Semin Arthritis Rheum 38, 132160 (2008).

    • Search Google Scholar
    • Export Citation
  • 103.

    Varga, J., Abraham, D.: Systemic sclerosis: A prototypic multisystem fibrotic disorder. J Clin Invest 117, 557567 (2007).

  • 104.

    Mayes, M. D.: Scleroderma epidemiology. Rheum Dis Clin North Am 29, 239254 (2003).

  • 105.

    Kissin, E. Y., Korn, J. H.: Fibrosis in scleroderma. Rheum Dis Clin North Am 29, 351369 (2003).

  • 106.

    Baraut, J., Farge, D., Jean-Louis, F., Kesmandt, H., Durant, C., Verrecchia, F., Michel, L.: [Cytokines in systemic sclerosis]. Pathol Biol (Paris) 60, 127139 (2012).

    • Search Google Scholar
    • Export Citation
  • 107.

    Wynn, T. A.: Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4, 583594 (2004).

  • 108.

    Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., Senior, R. M., Elias, J. A.: Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 194, 809821 (2001).

    • Search Google Scholar
    • Export Citation
  • 109.

    Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., Rabach, M. E., Shipley, J. M., Shapiro, S. D., Senior, R. M., Elias, J. A.: Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest 110, 463474 (2002).

    • Search Google Scholar
    • Export Citation
  • 110.

    Granel, B., Allanore, Y., Chevillard, C., Arnaud, V., Marquet, S., Weiller, P. J., Durand, J. M., Harle, J. R., Grange, C., Frances, Y., Berbis, P., Gaudart, J., de Micco, P., Kahan, A., Dessein, A.: IL13RA2 gene polymorphisms are associated with systemic sclerosis. J Rheumatol 33, 20152019 (2006).

    • Search Google Scholar
    • Export Citation
  • 111.

    Fuschiotti, P.: Role of IL-13 in systemic sclerosis. Cytokine 56, 544549 (2011).

  • 112.

    Aliprantis, A. O., Wang, J., Fathman, J. W., Lemaire, R., Dorfman, D. M., Lafyatis, R., Glimcher, L. H.: Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A 104, 28272830 (2007).

    • Search Google Scholar
    • Export Citation
  • 113.

    Rankin, A. L., Mumm, J. B., Murphy, E., Turner, S., Yu, N., McClanahan, T. K., Bourne, P. A., Pierce, R. H., Kastelein, R., Pflanz, S.: IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 184, 15261535 (2010).

    • Search Google Scholar
    • Export Citation
  • 114.

    Hasegawa, M., Fujimoto, M., Kikuchi, K., Takehara, K.: Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24, 328332 (1997).

    • Search Google Scholar
    • Export Citation
  • 115.

    Riccieri, V., Rinaldi, T., Spadaro, A., Scrivo, R., Ceccarelli, F., Franco, M. D., Taccari, E., Valesini, G.: Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol 22, 102106 (2003).

    • Search Google Scholar
    • Export Citation
  • 116.

    Fuschiotti, P., Medsger, T. A., Jr., Morel, P. A.: Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum 60, 11191128 (2009).

    • Search Google Scholar
    • Export Citation
  • 117.

    Fuschiotti, P.: CD8+ T cells in systemic sclerosis. Immunol Res 50, 188194 (2011).

  • 118.

    Falkner, D., Wilson, J., Fertig, N., Clawson, K., Medsger, T. A., Jr., Morel, P. A.: Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). J Rheumatol 27, 11961202 (2000).

    • Search Google Scholar
    • Export Citation
  • 119.

    Johnson, R. W., Tew, M. B., Arnett, F. C.: The genetics of systemic sclerosis. Curr Rheumatol Rep 4, 99107 (2002).

  • 120.

    Zheng, W., Flavell, R. A.: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587596 (1997).

    • Search Google Scholar
    • Export Citation
  • 121.

    Ouyang, W., Lohning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A., Murphy, K. M.: Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12, 2737 (2000).

    • Search Google Scholar
    • Export Citation
  • 122.

    Ho, I. C., Glimcher, L. H.: Transcription: Tantalizing times for T cells. Cell 109 Suppl, S109120 (2002).

  • 123.

    Zhou, M., Ouyang, W.: The function role of GATA-3 in Th1 and Th2 differentiation. Immunol Res 28, 2537 (2003).

  • 124.

    Lavenu-Bombled, C., Trainor, C. D., Makeh, I., Romeo, P. H., Max-Audit, I.: Interleukin-13 gene expression is regulated by GATA-3 in T cells: Role of a critical association of a GATA and two GATG motifs. J Biol Chem 277, 1831318321 (2002).

    • Search Google Scholar
    • Export Citation
  • 125.

    Kishikawa, H., Sun, J., Choi, A., Miaw, S. C., Ho, I. C.: The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol 167, 44144420 (2001).

    • Search Google Scholar
    • Export Citation
  • 126.

    Medsger, T. A., Jr., Ivanco, D. E., Kardava, L., Morel, P. A., Lucas, M. R., Fuschiotti, P.: GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. Arthritis Rheum 63, 17381747 (2011).

    • Search Google Scholar
    • Export Citation
  • 127.

    Tan, F. K., Zhou, X., Mayes, M. D., Gourh, P., Guo, X., Marcum, C., Jin, L., Arnett, F. C., Jr.: Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology ( Oxford) 45, 694702 (2006).

    • Search Google Scholar
    • Export Citation
  • 128.

    Paul, W. E., Zhu, J.: How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10, 225235 (2010).

  • 129.

    Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., Glimcher, L. H.: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655669 (2000).

    • Search Google Scholar
    • Export Citation
  • 130.

    Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., Glimcher, L. H.: Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338342 (2002).

    • Search Google Scholar
    • Export Citation
  • 131.

    Mullen, A. C., High, F. A., Hutchins, A. S., Lee, H. W., Villarino, A. V., Livingston, D. M., Kung, A. L., Cereb, N., Yao, T. P., Yang, S. Y., Reiner, S. L.: Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292, 19071910 (2001).

    • Search Google Scholar
    • Export Citation
  • 132.

    Usui, T., Preiss, J. C., Kanno, Y., Yao, Z. J., Bream, J. H., O’Shea, J. J., Strober, W.: T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med 203, 755766 (2006).

    • Search Google Scholar
    • Export Citation
  • 133.

    Suzuki, K., Kaminuma, O., Hiroi, T., Kitamura, F., Miyatake, S., Takaiwa, F., Tatsumi, H., Nemoto, S., Kitamura, N., Mori, A.: Downregulation of IL-13 gene transcription by T-bet in human T cells. Int Arch Allergy Immunol 146 Suppl 1, 3335 (2008).

    • Search Google Scholar
    • Export Citation
  • 134.

    Ho, I. C., Pai, S. Y.: GATA-3 — not just for Th2 cells anymore. Cell Mol Immunol 4, 1529 (2007).

  • 135.

    Gourh, P., Agarwal, S. K., Divecha, D., Assassi, S., Paz, G., Arora-Singh, R. K., Reveille, J. D., Shete, S., Mayes, M. D., Arnett, F. C., Tan, F. K.: Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: Evidence of possible gene–gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum 60, 37943806 (2009).

    • Search Google Scholar
    • Export Citation
  • 136.

    Mannon, P., Reinisch, W.: Interleukin 13 and its role in gut defence and inflammation. Gut 61, 17651773 (2012).

  • 137.

    Wu, D., Ahrens, R., Osterfeld, H., Noah, T. K., Groschwitz, K., Foster, P. S., Steinbrecher, K. A., Rothenberg, M. E., Shroyer, N. F., Matthaei, K. I., Finkelman, F. D., Hogan, S. P.: Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl-secretion. J Biol Chem 286, 1335713369 (2011).

    • Search Google Scholar
    • Export Citation
  • 138.

    Hering, N. A., Fromm, M., Schulzke, J. D.: Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 590, 10351044 (2012).

    • Search Google Scholar
    • Export Citation
  • 139.

    Bancroft, A. J., McKenzie, A. N., Grencis, R. K.: A critical role for IL-13 in resistance to intestinal nematode infection. J Immunol 160, 34533461 (1998).

    • Search Google Scholar
    • Export Citation
  • 140.

    Urban, J. F., Jr., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., Finkelman, F. D.: IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8, 255264 (1998).

    • Search Google Scholar
    • Export Citation
  • 141.

    Else, K. J., Grencis, R. K.: Antibody-independent effector mechanisms in resistance to the intestinal nematode parasite Trichuris muris. Infect Immun 64, 29502954 (1996).

    • Search Google Scholar
    • Export Citation
  • 142.

    Newcomb, D. C., Boswell, M. G., Huckabee, M. M., Goleniewska, K., Dulek, D. E., Reiss, S., Lukacs, N. W., Kolls, J. K., Peebles, R. S., Jr.: IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J Immunol 188, 10271035 (2012).

    • Search Google Scholar
    • Export Citation
  • 143.

    Newcomb, D. C., Zhou, W., Moore, M. L., Goleniewska, K., Hershey, G. K., Kolls, J. K., Peebles, R. S., Jr.: A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J Immunol 182, 53175321 (2009).

    • Search Google Scholar
    • Export Citation
  • 144.

    Newcomb, D. C., Boswell, M. G., Zhou, W., Huckabee, M. M., Goleniewska, K., Sevin, C. M., Hershey, G. K., Kolls, J. K., Peebles, R. S., Jr.: Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production. J Allergy Clin Immunol 127, 10061013, e10011004 (2011).

    • Search Google Scholar
    • Export Citation
  • 145.

    Boirivant, M., Fuss, I. J., Chu, A., Strober, W.: Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 188, 19291939 (1998).

    • Search Google Scholar
    • Export Citation
  • 146.

    Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., Strober, W.: Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17, 629638 (2002).

    • Search Google Scholar
    • Export Citation
  • 147.

    Scanlon, S. T., Thomas, S. Y., Ferreira, C. M., Bai, L., Krausz, T., Savage, P. B., Bendelac, A.: Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med 208, 21132124 (2011).

    • Search Google Scholar
    • Export Citation
  • 148.

    Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., Mannon, P., Strober, W.: Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113, 14901497 (2004).

    • Search Google Scholar
    • Export Citation
  • 149.

    Rosen, M. J., Frey, M. R., Washington, M. K., Chaturvedi, R., Kuhnhein, L. A., Matta, P., Revetta, F. L., Wilson, K. T., Polk, D. B.: STAT6 activation in ulcerative colitis: A new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis 17, 22242234 (2011).

    • Search Google Scholar
    • Export Citation
  • 150.

    Kawashima, R., Kawamura, Y. I., Oshio, T., Son, A., Yamazaki, M., Hagiwara, T., Okada, T., Inagaki-Ohara, K., Wu, P., Szak, S., Kawamura, Y. J., Konishi, F., Miyake, O., Yano, H., Saito, Y., Burkly, L. C., Dohi, T.: Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice–A pathway associated with ulcerative colitis. Gastroenterology 141, 21192129, e2118 (2011).

    • Search Google Scholar
    • Export Citation
  • 151.

    McDermott, J. R., Humphreys, N. E., Forman, S. P., Donaldson, D. D., Grencis, R. K.: Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection. J Immunol 175, 32073213 (2005).

    • Search Google Scholar
    • Export Citation
  • 152.

    Gonsalves, N., Yang, G. Y., Doerfler, B., Ritz, S., Ditto, A. M., Hirano, I.: Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 142, 14511459, e1451; quiz e1414–1455 (2012).

    • Search Google Scholar
    • Export Citation
  • 153.

    Mishra, A., Rothenberg, M. E.: Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 125, 14191427 (2003).

    • Search Google Scholar
    • Export Citation
  • 154.

    Akei, H. S., Mishra, A., Blanchard, C., Rothenberg, M. E.: Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 129, 985994 (2005).

    • Search Google Scholar
    • Export Citation
  • 155.

    Zuo, L., Fulkerson, P. C., Finkelman, F. D., Mingler, M., Fischetti, C. A., Blanchard, C., Rothenberg, M. E.: IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol 185, 660669 (2010).

    • Search Google Scholar
    • Export Citation
  • 156.

    Neilsen, C. V., Bryce, P. J.: Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin Exp Allergy 40, 427434 (2010).

    • Search Google Scholar
    • Export Citation
  • 157.

    Blanchard, C., Stucke, E. M., Rodriguez-Jimenez, B., Burwinkel, K., Collins, M. H., Ahrens, A., Alexander, E. S., Butz, B. K., Jameson, S. C., Kaul, A., Franciosi, J. P., Kushner, J. P., Putnam, P. E., Abonia, J. P., Rothenberg, M. E.: A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol 127, 208217, e201207 (2011).

    • Search Google Scholar
    • Export Citation
  • 158.

    Frischmeyer-Guerrerio, P. A., Guerrerio, A. L., Chichester, K. L., Bieneman, A. P., Hamilton, R. A., Wood, R. A., Schroeder, J. T.: Dendritic cell and T cell responses in children with food allergy. Clin Exp Allergy 41, 6171 (2011).

    • Search Google Scholar
    • Export Citation
  • 159.

    Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., Wynn, T. A.: An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104, 777785 (1999).

    • Search Google Scholar
    • Export Citation
  • 160.

    Matsushita, M., Yamamoto, T., Nishioka, K.: Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Int Arch Allergy Immunol 135, 348356 (2004).

    • Search Google Scholar
    • Export Citation
  • 161.

    Wallace, W. A., Ramage, E. A., Lamb, D., Howie, S. E.: A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 101, 436441 (1995).

    • Search Google Scholar
    • Export Citation
  • 162.

    Wilson, M. S., Wynn, T. A.: Pulmonary fibrosis: Pathogenesis, etiology and regulation. Mucosal Immunol 2, 103121 (2009).

  • 163.

    Scharl, M., Frei, S., Pesch, T., Kellermeier, S., Arikkat, J., Frei, P., Fried, M., Weber, A., Jehle, E., Ruhl, A., Rogler, G.: Interleukin-13 and transforming growth factor beta synergise in the pathogenesis of human intestinal fistulae. Gut 62, 6372 (2013).

    • Search Google Scholar
    • Export Citation
  • 164.

    Badalyan, V., Thompson, R. W., Wynn, T. A., Ramalingam, T. R.: Tu1723 TNFA and IL-17 synergize to inhibit IL-13 bioactivity via IL-13Ra2 induction in human colonic fibroblasts. Gastroenterology 146, S–826 (2014).

    • Search Google Scholar
    • Export Citation
  • 165.

    Kobayashi, M., Kobayashi, H., Pollard, R. B., Suzuki, F.: A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol 160, 58695873 (1998).

    • Search Google Scholar
    • Export Citation
  • 166.

    Terabe, M., Park, J. M., Berzofsky, J. A.: Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother 53, 7985 (2004).

    • Search Google Scholar
    • Export Citation
  • 167.

    Kacha, A. K., Fallarino, F., Markiewicz, M. A., Gajewski, T. F.: Cutting edge: Spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice. J Immunol 165, 60246028 (2000).

    • Search Google Scholar
    • Export Citation
  • 168.

    Ostrand-Rosenberg, S., Grusby, M. J., Clements, V. K.: Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol 165, 60156019 (2000).

    • Search Google Scholar
    • Export Citation
  • 169.

    Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., Berzofsky, J. A.: NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1, 515520 (2000).

    • Search Google Scholar
    • Export Citation
  • 170.

    Terabe, M., Matsui, S., Park, J. M., Mamura, M., Noben-Trauth, N., Donaldson, D. D., Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., Letterio, J. J., Paul, W. E., Berzofsky, J. A.: Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence. J Exp Med 198, 17411752 (2003).

    • Search Google Scholar
    • Export Citation
  • 171.

    Ostrand-Rosenberg, S., Clements, V. K., Terabe, M., Park, J. M., Berzofsky, J. A., Dissanayake, S. K.: Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent. J Immunol 169, 57965804 (2002).

    • Search Google Scholar
    • Export Citation
  • 172.

    Ahlers, J. D., Belyakov, I. M., Terabe, M., Koka, R., Donaldson, D. D., Thomas, E. K., Berzofsky, J. A.: A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. Proc Natl Acad Sci U S A 99, 1302013025 (2002).

    • Search Google Scholar
    • Export Citation
  • 173.

    Berzofsky, J. A., Ahlers, J. D., Belyakov, I. M.: Strategies for designing and optimizing new generation vaccines. Nat Rev Immunol 1, 209219 (2001).

    • Search Google Scholar
    • Export Citation
  • 174.

    Kawakami, K., Kawakami, M., Snoy, P. J., Husain, S. R., Puri, R. K.: In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice. J Exp Med 194, 17431754 (2001).

    • Search Google Scholar
    • Export Citation
  • 175.

    Lebel-Binay, S., Laguerre, B., Quintin-Colonna, F., Conjeaud, H., Magazin, M., Miloux, B., Pecceu, F., Caput, D., Ferrara, P., Fradelizi, D.: Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13. Eur J Immunol 25, 23402348 (1995).

    • Search Google Scholar
    • Export Citation
  • 176.

    Chaouchi, N., Wallon, C., Goujard, C., Tertian, G., Rudent, A., Caput, D., Ferrera, P., Minty, A., Vazquez, A., Delfraissy, J. F.: Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87, 10221029 (1996).

    • Search Google Scholar
    • Export Citation
  • 177.

    Kawakami, K., Joshi, B. H., Puri, R. K.: Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain. Hum Gene Ther 11, 18291835 (2000).

    • Search Google Scholar
    • Export Citation
  • 178.

    Joshi, B. H., Kawakami, K., Leland, P., Puri, R. K.: Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: Differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin. Clin Cancer Res 8, 19481956 (2002).

    • Search Google Scholar
    • Export Citation
  • 179.

    Gabay, C., Porter, B., Guenette, D., Billir, B., Arend, W. P.: Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: Differential effect on C-reactive protein production. Blood 93, 12991307 (1999).

    • Search Google Scholar
    • Export Citation
  • 180.

    Kawakami, K., Husain, S. R., Bright, R. K., Puri, R. K.: Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts. Cancer Gene Ther 8, 861868 (2001).

    • Search Google Scholar
    • Export Citation
  • 181.

    Kanai, T., Watanabe, M., Hayashi, A., Nakazawa, A., Yajima, T., Okazawa, A., Yamazaki, M., Ishii, H., Hibi, T.: Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. Br J Cancer 82, 17171723 (2000).

    • Search Google Scholar
    • Export Citation
  • 182.

    Kapp, U., Yeh, W. C., Patterson, B., Elia, A. J., Kagi, D., Ho, A., Hessel, A., Tipsword, M., Williams, A., Mirtsos, C., Itie, A., Moyle, M., Mak, T. W.: Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 189, 19391946 (1999).

    • Search Google Scholar
    • Export Citation
  • 183.

    Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Patterson, B., Trumper, L., Kapp, U., Mak, T. W.: Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99, 618626 (2002).

    • Search Google Scholar
    • Export Citation
  • 184.

    Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Trumper, L. H., von Bonin, F., Kapp, U., Patterson, B., Snow, B. E., Mak, T. W.: Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 97, 250255 (2001).

    • Search Google Scholar
    • Export Citation
  • 185.

    Skinnider, B. F., Kapp, U., Mak, T. W.: The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43, 12031210 (2002).

  • 186.

    Kawakami, M., Leland, P., Kawakami, K., Puri, R. K.: Mutation and functional analysis of IL-13 receptors in human malignant glioma cells. Oncol Res 12, 459467 (2001).

    • Search Google Scholar
    • Export Citation
  • 187.

    Babaloo, Z., Kaye, P. M., Eslami, M. B.: Interleukin-13 in Iranian patients with visceral leishmaniasis: Relationship to other Th2 and Th1 cytokines. T Roy Soc Trop Med H 95, 8588 (2001).

    • Search Google Scholar
    • Export Citation
  • 188.

    Chen, L., Shen, Y., Liu, L., Li, X., Wang, T., Wen, F.: Interleukin-13 — 1112 C/T promoter polymorphism confers risk for COPD: A meta-analysis. PLoS ONE 8, e68222 (2013).

    • Search Google Scholar
    • Export Citation
  • 189.

    Seyfizadeh, N., Kazemi, T., Farhoudi, M., Aliparasti, M. R., Sadeghi-Bazargani, H., Almasi, S., Babaloo, Z.: Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis. Am J Clin Exp Immunol 3, 124 (2014).

    • Search Google Scholar
    • Export Citation
  • 190.

    Yang, G., Volk, A., Petley, T., Emmell, E., Giles-Komar, J., Shang, X., Li, J., Das, A. M., Shealy, D., Griswold, D. E., Li, L.: Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28, 224232 (2004).

    • Search Google Scholar
    • Export Citation
  • 191.

    Oh, C., Geba, G., Molfino, N.: Investigational therapeutics targeting the IL-4/IL-13/ STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19, 4654 (2010).

    • Search Google Scholar
    • Export Citation
  • 192.

    Holgate, S. T.: Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol 128, 495505 (2011).

    • Search Google Scholar
    • Export Citation
  • 193.

    Mitchell, J., Dimov, V., Townley, R. G.: IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease. Curr Opin Investig Drugs (London, England: 2000) 11, 527534 (2010).

    • Search Google Scholar
    • Export Citation
  • 194.

    Kasaian, M. T., Donaldson, D. D., Tchistiakova, L., Marquette, K., Tan, X. Y., Ahmed, A., Jacobson, B. A., Widom, A., Cook, T. A., Xu, X., Barry, A. B., Goldman, S. J., Abraham, W. M.: Efficacy of IL-13 neutralization in a sheep model of experimental asthma. Am J Respir Cell Mol Biol 36, 368376 (2007).

    • Search Google Scholar
    • Export Citation
  • 195.

    Bree, A., Schlerman, F. J., Wadanoli, M., Tchistiakova, L., Marquette, K., Tan, X. Y., Jacobson, B. A., Widom, A., Cook, T. A., Wood, N., Vunnum, S., Krykbaev, R., Xu, X., Donaldson, D. D., Goldman, S. J., Sypek, J., Kasaian, M. T.: IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J Allergy Clin Immunol 119, 12511257 (2007).